Skip to Content
You are currently on the new version of our website. Access the old version .
MDPIMDPI

Advanced

Biology and Life Sciences ForumBiology and Life Sciences Forum
PDF
  • Proceeding Paper
  • Open Access

30 September 2022

4 Pages

Algal-Derived Hydrocolloids with Potential Antiviral Activity: A Mechanistic Approach †

,
and
1
Network of Chemistry and Technology/Associated Laboratory for Green Chemistry (REQUIMTE/LAQV), Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4099-002 Porto, Portugal
2
Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Food Science and Technology, University of Vigo, Ourense Campus, 32004 Ourense, Spain
*
Author to whom correspondence should be addressed.
†
Presented at the 3rd International Electronic Conference on Foods: Food, Microbiome, and Health—A Celebration of the 10th Anniversary of Foods’ Impact on Our Wellbeing; Available online: https://sciforum.net/event/Foods2022.
Biol. Life Sci. Forum2022, 18(1), 23;https://doi.org/10.3390/Foods2022-13003
This article belongs to the Proceedings of The 3rd International Electronic Conference on Foods: Food, Microbiome, and Health—A Celebration of the 10th Anniversary of Foods’ Impact on Our Wellbeing
Version Notes
Order Reprints

Abstract

From a structural point of view, hydrocolloids are characterized as hydrophilic biopolymers with high molecular weight. Hydrocolloids are widely used in the food industry, mainly as thickeners, gelling agents, stabilizers of foams and emulsions, and inhibitors of ice and sugar crystals. Additionally, hydrocolloids are being increasingly used as fat replacers, aiming to produce low-calorie foods. Besides these important functional properties in different food products, hydrocolloids are being progressively recognized for their diverse biological properties, including anticoagulant, antithrombic, hypocholesterolemic, antioxidant, antiviral, antitumor, and immunomodulatory effects. Additionally, some studies have reported that these biopolymers have beneficial effects against a significant number of dermatological problems. Regarding antiviral properties, some hydrocolloids, such as sulfated polysaccharides, exhibit unique structures that exert these effects. This study aims to describe the corresponding underlying mechanisms of this bioactivity. Special attention will be given to the way hydrocolloids may obstruct different phases of the viral life cycle (attachment, penetration, uncoating, biosynthesis, viral assembly, and release) by directly inactivating virions before infection or by inhibiting its replication inside the host cell. The presented information might represent a potential contribution to the discovery and development of new antiviral drugs.

1. Occurrence of Sulfated Polysaccharides in Algal Species

1.1. Red Macroalgae

In red macroalgae, sulfated galactans stand out as the major polysaccharides. From a structural point of view, these compounds are characterized by their typical linear backbone with alternating units of β-D-galactopyranose (with the glycosidic bond in carbon 3) and α-galactopyranose (with the glycosidic bond in carbon 4). Sulfated galactans are generally divided in agarans, in which the monomeric unit is α-L-galactose, and carrageenans, which, are formed by linear chains of α-D-galactose [1].
In red algae, carrageenan is located in the outer cell wall and in the intracellular matrix and may correspond to as much as 30–70% of their dry weight. In what concerns its metabolic pathway, carrageenan is initially produced in the Golgi apparatus and later sulfated by sulfotransferases in the cell wall [2].
The carrageenans with the highest commercial relevance, are kappa (κ), which is naturally abundant, for instance, in Kappaphycus alvarezii and several Eucheuma species [3]; iota (ι), found in high percentages in Eucheuma denticulatum [4]; and lambda (λ), which is abundant, together with other red algae, in Gigartina skottsbergii and Chondrus crispus [5,6].
Aside from carrageenan, agar is also common in red macroalgae. Agar comprises two polysaccharides, agarose and agaropectin, and it is particularly abundant in the genera Gelidium and Gracilaria. From a structural point of view, agar contains alternating sequences of 1→3-β-D-galactopyranose (which can be substituted by sulfate esters, pyruvic acid acetals, or methoxy groups) and 1→4-α-L-galactopyranose or 3→6-α-L-galactopyranose [7,8].

1.2. Green Macroalgae

Ulvan is the most common polysaccharide in the cell walls of green seaweed, being most commonly found in genera such as Ulva, Gayralia, and Monostroma. Despite representing a less exuberant percentage than carrageenan in red macroalgae, ulvan can reach 8–29% of the algal dry weight [9]. It is mainly constituted by L-rhamnose (5.0–92.2%), D-glucuronic acid (2.6–52.0%), D-xylose (0.0–38.0%), L-iduronic acid (0.6–15.3%), and sulfate [10]. These monomeric units are typically linked by α- and β-(1→4) bonds, forming repeating disaccharide units, such as aldobiuronic acids (or ulvanobiuronic acid) and aldobioses (or ulvanobioses) [11].

1.3. Brown Macroalgae

Among brown macroalgae, fucoidan is acknowledged as the major sulfated polysaccharide, often reaching percentages as high as 30% of its dry weight. Fucoidan is characterized by a backbone of α-(1→3)-L-fucopyranosyl residues with α-(1→3) or α-(1→4) glycosidic bonds positions [12]. Nonetheless, fucoidan is classified as an heterogenous polysaccharide since the pyranose unit may be substituted by sulfate, acetate, or glycosyl (e.g., glucuronic acid) units and, less frequently, other monosaccharides (e.g., D-xylose, D-galactose, D-mannose, or uronic acids) [13].
Fucus evanescens and Ascophyllum nodosum are typical sources of fucoidan [12].

2. Antiviral Activity of Algae-Derived of Sulfated Polysaccharides

Owing to their unique chemical structures, algae-sulfated polysaccharides may exert different biological activities.
In the specific case of their potential antiviral effects, these compounds may block different phases of the viral life cycle, either by direct inactivation of virions before infection, or by inhibiting its replication inside the host cell. Accordingly, a significant number of antiviral drugs have been developed based in the capacity of algae polysaccharides to inhibit the primary stages (attachment, penetration, uncoating, biosynthesis, viral assembly, and release) of the virus life cycle [14].

2.1. Antiviral Activity of Red Macroalgae Sulfated Polysaccharides

Possibly due to its higher natural occurrence, carrageenan is the most studied sulfated polysaccharide in human clinical trials designed to evaluate its potential effect against various viral diseases [15]. Kappa-(κ-)carrageenan, particularly in low-molecular weight forms, showed capacity to inhibit viral replication, either by blocking adsorption to the surface, or by inhibiting protein expression [16]. This action was reported in different viral species, such as the influenza virus [16], severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [17], herpes simplex virus type 2 (HSV-2), and human papilloma virus subtype 16 (HPV16) [18].
On the other hand, lambda-(λ-)carrageenan inhibits viral internalization by specifically targeting cell surface receptors in which virus attachment occurs or through binding to viral envelope proteins. This effect has been reported in rabies virus infection [19], influenza, SARS-CoV-2 [20], different herpes viruses [20], and dengue virus [21].
Iota-(ι-)carrageenan’s antiviral activity has also been well documented, especially against respiratory viruses [22]. Likewise, it seems to contribute to the neutralization of SARS-CoV-2, particularly because of positively charged regions on the glycoprotein envelope and protein aggregation on host cells’ surface [23].
Additionally, galactans show good antiviral activity against herpes simplex virus (HSV), dengue virus, hepatitis A virus, and human immunodeficiency virus (HIV) (preventing the interaction between HIV gp120 and the cluster of differentiation (CD)4 + T-cell receptor) [24].

2.2. Antiviral Activity of Green Macroalgae Sulfated Polysaccharides

Ulvan, the major sulfated polysaccharide in green macroalgae, was reported for its in vitro and in vivo antiviral activity [25], for instance, by preventing the infection and replication of the vesicular stomatitis virus [26], by reducing the formation of syncytia in the measles virus [27], by inhibiting cell-to-cell fusion in the Newcastle disease virus [28], or by downregulating protein synthesis in HSV [29].

2.3. Antiviral Activity of Sulfated Brown Macroalgae Polysaccharides

Due to its abundance in these algae species, fucoidan is the most commonly studied polysaccharide, already having been reported as being effective against several RNA and DNA viruses, including HIV (by reducing the p24 antigen and reverse transcriptase levels), HSV, influenza A virus (by blocking neuraminidase activity), and SARS-CoV-2, among others [30,31].

3. Conclusions

Comparing the algae species referred to above, it seems evident that red and brown algae have higher potential as sources of sulfated polysaccharides, which may justify that these species are studied in further depth. Independently of algae source, sulfated polysaccharides showed activity against various DNA and RNA viruses. The associated antiviral mechanisms and corresponding effectiveness appear to be highly dependent on virus species and host cell type. Nevertheless, algae-derived sulfated polysaccharides seem to have a validated antiviral activity, which, conjugated with their high availability, low production costs, broad-spectrum antiviral activities, and unique antiviral mechanisms, suggest that their exploitation for this purpose may be particularly attractive.

Author Contributions

Conceptualization, C.S.G.P.P. and M.B.P.P.O.; validation, M.A.P. and M.B.P.P.O.; formal analysis, M.A.P. and M.B.P.P.O.; investigation, C.S.G.P.P.; writing—original draft preparation, C.S.G.P.P.; writing—review and editing, C.S.G.P.P., M.A.P. and M.B.P.P.O.; supervision, M.A.P. and M.B.P.P.O. All authors have read and agreed to the published version of the manuscript.

Funding

The research leading to these results was funded by Foundation for Science and Technology (FCT, Portugal) through the PhD grant attributed to Cláudia S.G.P. Pereira (2021.09490.BD), and MICINN through the Ramón y Cajal grant attributed to Miguel A. Prieto (RYC-2017-22891).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Al-Alawi, A.A.; Al-Marhubi, I.M.; Al-Belushi, M.S.M.; Soussi, B. Characterization of carrageenan extracted from Hypnea bry-oides in Oman. Mar. Biotechnol. 2011, 13, 893–899. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Garcia-Jimenez, P.; Mantesa, S.R.; Robaina, R.R. Expression of Genes Related to Carrageenan Synthesis during Carposporogenesis of the Red Seaweed Grateloupia imbricata. Mar. Drugs 2020, 18, 432. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Rudke, A.R.; de Andrade, C.J.; Ferreira, S.R.S. Kappaphycus alvarezii macroalgae: An unexplored and valuable biomass for green biorefinery conversion. Trends Food Sci. Technol. 2020, 103, 214–224. [Google Scholar] [CrossRef] [Scilit]
  4. Jönsson, M.; Allahgholi, L.; Sardari, R.R.; Hreggviðsson, G.O.; Nordberg Karlsson, E. Extraction and modification of macroalgal polysaccharides for current and next-generation applications. Molecules 2020, 25, 930. [Google Scholar] [CrossRef] [Scilit]
  5. Zhu, B.; Ni, F.; Sun, Y.; Zhu, X.; Yin, H.; Yao, Z.; Du, Y. Insight into carrageenases: Major review of sources, category, property, purification method, structure, and applications. Crit. Rev. Biotechnol. 2018, 38, 1261–1276. [Google Scholar] [CrossRef] [Scilit]
  6. Muthukumar, J.; Chidambaram, R.; Sukumaran, S. Sulfated polysaccharides and its commercial applications in food industries—A review. J. Food Sci. Technol. 2020, 58, 2453–2466. [Google Scholar] [CrossRef] [Scilit]
  7. Usov, A.I. Polysaccharides of the red algae. In Advances in Carbohydrate Chemistry and Biochemistry; Horton, D., Ed.; Academic Press: Cambridge, MA, USA, 2011; pp. 115–217. [Google Scholar]
  8. Lee, W.K.; Lim, Y.Y.; Leow, A.T.C.; Namasivayam, P.; Ong Abdullah, J.; Ho, C.L. Biosynthesis of agar in red seaweeds: A review. Carbohydr. Polym. 2017, 164, 23–30. [Google Scholar] [CrossRef] [Scilit]
  9. Lahaye, M.; Robic, A. Structure and functional properties of ulvan, a polysaccharide from green seaweeds. Biomacromolecules 2007, 8, 1765–1774. [Google Scholar] [CrossRef] [Scilit]
  10. Kim, S.K. Springer Handbook of Marine Biotechnology; Springer: Berlin/Heidelberg, Germany, 2015; pp. 941–953. [Google Scholar]
  11. Kidgell, J.T.; Magnusson, M.; de Nys, R.; Glasson, C.R.K. Ulvan: A systematic review of extraction, composition and function. Algal Res. 2019, 39, 101422. [Google Scholar] [CrossRef] [Scilit]
  12. Yuguchi, Y.; Bui, L.M.; Takebe, S.; Suzuki, S.; Nakajima, N.; Kitamura, S.; Thanh, T.T.T. Primary structure, conformation in aqueous solution, and intestinal immunomodulating activity of fucoidan from two brown seaweed species Sargassum crassifo-lium and Padina australis. Carbohydr. Polym. 2016, 147, 69–78. [Google Scholar] [CrossRef] [Scilit]
  13. Ale, M.T.; Mikkelsen, J.D.; Meyer, A.S. Important Determinants for Fucoidan Bioactivity: A Critical Review of Structure-Function Relations and Extraction Methods for Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds. Mar. Drugs 2011, 9, 2106–2130. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Wang, W.; Wang, S.-X.; Guan, H.-S. The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview. Mar. Drugs 2012, 10, 2795–2816. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Perino, A.; Consiglio, P.; Maranto, M.; de Franciscis, P.; Marci, R.; Restivo, V.; Manzone, M.; Capra, G.; Cucinella, G.; Calagna, G. Impact of a new carrageenan-based vaginal microbicide in a female population with genital HPV-infection: First experi-mental results. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 6744–6752. [Google Scholar]
  16. Wang, W.; Zhang, P.; Hao, C.; Zhang, X.-E.; Cui, Z.-Q.; Guan, H.-S. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antivir. Res. 2011, 92, 237–246. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. Schütz, D.; Conzelmann, C.; Fois, G.; Gross, R.; Weil, T.; Wettstein, L.; Stenger, S.; Zelikin, A.; Hoffmann, T.K.; Frick, M.; et al. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epi-thelial cultures. Am. J. Physiol. Lung Cell Mol. Physiol. 2021, 320, 750–756. [Google Scholar] [CrossRef] [Scilit]
  18. Buck, C.B.; Thompson, C.D.; Roberts, J.N.; Muller, M.; Lowy, D.R.; Schiller, J.T. Carrageenan is a potent inhibitor of papillo-mavirus infection. PLoS Pathog. 2006, 2, 69. [Google Scholar] [CrossRef] [Scilit]
  19. Luo, Z.; Tian, D.; Zhou, M.; Xiao, W.; Zhang, Y.; Li, M.; Sui, B.; Wang, W.; Guan, H.; Chen, H.; et al. lamb-da-carrageenan P32 is a potent inhibitor of rabies virus Infection. PLoS ONE 2015, 10, 0140586. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  20. Jang, Y.; Shin, H.; Lee, M.K.; Kwon, O.S.; Shin, J.S.; Kim, Y.I.; Kim, C.W.; Lee, H.R.; Kim, M. Antiviral activity of lamb-dacarrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2. Sci. Rep. 2021, 11, 821. [Google Scholar] [CrossRef] [Scilit]
  21. Talarico, L.B.; Damonte, E.B. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 2007, 363, 473–485. [Google Scholar] [CrossRef] [Scilit]
  22. Morokutti-Kurz, M.; Graf, C.; Prieschl-Grassauer, E. Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carra-geenan lozenges as active treatments for sore throat. Int. J. Gen. Med. 2017, 10, 53–60. [Google Scholar] [CrossRef] [Scilit]
  23. Hassanzadeh, K.; Pena, H.P.; Dragotto, J.; Buccarello, L.; Iorio, F.; Pieraccini, S.; Sancini, G.; Feligioni, M. Considerations around the SARS-CoV-2 spike protein with particular attention to COVID-19 brain infection and neurological symptoms. ACS Chem. Neurosci. 2020, 11, 2361–2369. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. Ahmadi, A.; Moghadamtousi, S.Z.; Abubakar, S.; Zandi, K. Antiviral potential of algae polysaccharides isolated from marine sources: A Review. BioMed Res. Int. 2015, 2015, 825203. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Hardouin, K.; Bedoux, G.; Burlot, A.S.; Donnay-Moreno, C.; Bergé, J.P.; Nyvall-Collén, P.; Bourgougnon, N. Enzyme-assisted extraction (EAE) for the production of antiviral and antioxidant extracts from the green seaweed Ulva armoricana (Ulvales, Ulvophyceae). Algal Res. 2016, 16, 233–239. [Google Scholar] [CrossRef] [Scilit]
  26. Chi, Y.; Zhang, M.; Wang, X.; Fu, X.; Guan, H.; Wang, P. Ulvan lyase assisted structural characterization of ulvan from Ulva pertusa and its antiviral activity against vesicular stomatitis virus. Int. J. Biol. Macromol. 2020, 157, 75–82. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Morán-Santibañez, K.; Cruz-Suárez, L.E.; Ricque-Marie, D.; Robledo, D.; Freile-Pelegrín, Y.; Peña-Hernández, M.A.; Rodríguez-Padilla, C.; Trejo-Avila, L.M. Synergistic effects of sulfated polysaccharides from Mexican seaweeds against measles virus. Biomed. Res. Int. 2016, 2016, 8502123. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  28. Aguilar-Briseño, J.A.; Cruz-Suárez, L.E.; Sassi, J.F.; Ricque-Marie, D.; Zapata-Benavides, P.; Mendoza-Gamboa, E.; Rodríguez-Padilla, C.; Trejo-Avila, L.M. Sulphated polysaccharides from Ulva clathrata and Cladosiphon okamuranus sea-weeds both inhibit viral attachment/entry and cell-cell fusion, in NDV infection. Mar. Drugs 2015, 13, 697–712. [Google Scholar] [CrossRef] [Scilit]
  29. Lopes, N.; Ray, S.; Espada, S.F.; Bomfim, W.A.; Ray, B.; Faccin-Galhardi, L.C.; Linhares, R.E.C.; Nozawa, C. Green seaweed Enteromorpha compressa (Chlorophyta, Ulvaceae) derived sulphated polysaccharides inhibit herpes simplex virus. Int. J. Biol. Macromol. 2017, 102, 605–612. [Google Scholar] [CrossRef] [Scilit]
  30. Dinesh, S.; Menon, T.; Hanna, L.E.; Suresh, V.; Sathuvan, M.; Manikannan, M. In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii. Int. J. Biol. Macromol. 2016, 82, 83–88. [Google Scholar] [CrossRef] [Scilit]
  31. Jiao, G.; Yu, G.; Wang, W.; Zhao, X.; Zhang, J.; Ewart, S.H. Properties of polysaccharides in several seaweeds from Atlantic Canada and their potential anti-influenza viral activities. J. Ocean Univ. China 2012, 11, 205–212. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Optimization of Pigment Extraction from Quinoa Flour Fermented by Monascus purpureus Supplemented with Fish Hydrolysate and Sodium Chloride
Previous
Printability Prediction of Three Gels for 3D Food Printing
Next